Medical groups sue EPA over mercury rule

Article Abstract:

Several National Health Organizations joined a lawsuit against the Environment Protection Agency (EPA) alleging that the agency's finalized rules on mercury emissions from power plants failed to protect children and fetuses from the toxin's harmful effects. The lawsuit, claims that the EPA acted illegally in exempting coal- and oil- fired power plants from a list of industrial pollution sources governed by the strict pollution control requirements of the Clean Air Act.

Professional Organizations, Medical Associations, Company legal issue, Cases, Environmental protection, Medical societies, Environmental issue

---

Industry, FDA warm to "adaptive" trials

Article Abstract:

Pharmaceutical companies and the Food and Drug Administration are considering the use of adaptive clinical trials in which data are analyzed on an interim basis while the studies are in progress, and this emerging data is used to dictate the future course of the trial as a way to speed new drugs to market. These adaptive trials have also attracted criticism that their results are more difficult to interpret and more vulnerable to unblinding and bias.

Management dynamics, Management, Clinical trials, Company business management

---

FDA warns claims for pharmacy-made "bio-identical" hormones are misleading

Article Abstract:

The Food and Drug Administration (FDA) has asked pharmacies not to make false claims about the so-called "bio-identical" hormone replacement therapy products they are marketing.

Public affairs, Ethics, Ethical aspects, Hormone therapy, Hormone replacement therapy

Similar abstracts:

• Abstracts: Medicare HMO pilot stalls: Denver lawsuit raises question. N.Y. HMO will pay for sign language interpreters
• Abstracts: Procedural volume as a marker of quality for CABG surgery. Pay for performance, quality of care, and outcomes in acute myocardial infarction
• Abstracts: Molecular switch triggers fats' harm. Erectile dysfunction and subsequent cardiovascular disease. The global burden of chronic diseases: overcoming impediments to prevention and control
• Abstracts: Six-month androgen suppression plus radiation therapy vs. radiation therapy alone for patients with clinically localized prostate cancer
• Abstracts: Congress preview: what to expect in New Orleans for the 87th Annual Congress & Expo. Technical Sessions

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.